Tomassini, Valentina http://orcid.org/0000-0002-7368-6280
Sinclair, Audrey
Sawlani, Vijay
Overell, James
Pearson, Owen R.
Hall, Julie
Guadagno, Joe
Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited (Support for meeting)
Article History
Received: 17 January 2020
Revised: 12 May 2020
Accepted: 18 May 2020
First Online: 29 May 2020
Compliance with ethical standards
:
: Dr. Tomassini received honoraria to attend advisory boards and for lectures from Biogen, Novartis, Genzyme Sanofi. Dr. Sinclair received support for attending scientific meetings and speakers’ fees from Merck and Biogen. Dr Sawlani received honoraria to attend advisory boards and speaker fees from Novartis. Dr. Pearson received honoraria and support to attend scientific meetings, speakers’ fees and advisory boards from Biogen, Genzyme, Merck Serono, Novartis, Roche and Teva. Dr. Overell has received honoraria for speaking engagements and attendance at advisory boards, and conference travel support from Teva, Novartis, Merck Serono, Genzyme, Hoffmann-La Roche, Allergan, WebMD Global and Biogen. His Department has received educational funds, research support and funds to provide nursing and administrative staff from Novartis, Genzyme, Roche and Biogen. Since March 2019, he has been an employee and shareholder of F. Hoffmann-La Roche Ltd.
: This article does not contain any studies with human participants or animals performed by any of the authors.